Nu Skin Enterprises (NYSE:NUS) Issues Quarterly Earnings Results

Nu Skin Enterprises (NYSE:NUS) posted its quarterly earnings results on Wednesday. The company reported $0.09 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.04, Briefing.com reports. The business had revenue of $417.31 million during the quarter, compared to the consensus estimate of $426.55 million. Nu Skin Enterprises had a return on equity of 10.73% and a net margin of 0.44%. The company’s revenue for the quarter was down 13.3% compared to the same quarter last year. During the same period last year, the firm earned $0.37 earnings per share.

Nu Skin Enterprises Stock Performance

NUS stock traded up $0.19 during trading on Thursday, reaching $12.61. 376,887 shares of the company’s stock were exchanged, compared to its average volume of 725,236. Nu Skin Enterprises has a 1-year low of $11.73 and a 1-year high of $38.23. The company’s fifty day moving average price is $12.66 and its 200-day moving average price is $15.89. The company has a quick ratio of 1.28, a current ratio of 2.13 and a debt-to-equity ratio of 0.58. The firm has a market cap of $623.19 million, a PE ratio of 70.56 and a beta of 1.13.

Nu Skin Enterprises Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 6th. Investors of record on Monday, February 26th were given a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 1.90%. The ex-dividend date was Friday, February 23rd. Nu Skin Enterprises’s dividend payout ratio is currently 133.34%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on NUS. DA Davidson lowered their target price on Nu Skin Enterprises from $15.50 to $12.50 and set a “neutral” rating for the company in a report on Thursday. StockNews.com lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday, February 24th. Four investment analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $20.83.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.